Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Roos

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|June 19, 2019
Genomics-Enabled Precision Medicine for CancerAlison Roos, Sara A Byron
Frontiers in Oncology|July 4, 2017
Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and InvasionAlison Roos, Zonghui Ding, Joseph C Loftus, et al.
Journal of Virology|October 4, 2013
Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cellsMaria Teresa Sáenz Robles, Chikdu Shivalila, Jeremy Wano, et al.
British Journal of Cancer|November 4, 2015
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosisAlison Roos, Laura Satterfield, Shuying Zhao, et al.
Molecular Cancer Research : MCR|November 10, 2017
A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell InvasionZonghui Ding, Alison Roos, Jean Kloss, et al.
Journal of Neuro-Oncology|November 13, 2015
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathwayHarshil D Dhruv, Alison Roos, Patrick J Tomboc, et al.
Frontiers in Oncology|December 12, 2024
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1Zachary D Wallen, Mary K Nesline, Marni Tierno, et al.
Neuro-Oncology|June 14, 2018
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistanceDavid S Hersh, Bryan G Harder, Alison Roos, et al.
Molecular Cancer Research : MCR|January 15, 2016
SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to TemozolomideShannon P Fortin Ensign, Alison Roos, Ian T Mathews, et al.
Molecular Cancer Research : MCR|May 5, 2018
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and SurvivalAlison Roos, Harshil D Dhruv, Sen Peng, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|June 19, 2019
Genomics-Enabled Precision Medicine for CancerAlison Roos, Sara A Byron
Frontiers in Oncology|July 4, 2017
Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and InvasionAlison Roos, Zonghui Ding, Joseph C Loftus, et al.
Journal of Virology|October 4, 2013
Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cellsMaria Teresa Sáenz Robles, Chikdu Shivalila, Jeremy Wano, et al.
British Journal of Cancer|November 4, 2015
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosisAlison Roos, Laura Satterfield, Shuying Zhao, et al.
Molecular Cancer Research : MCR|November 10, 2017
A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell InvasionZonghui Ding, Alison Roos, Jean Kloss, et al.
Journal of Neuro-Oncology|November 13, 2015
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathwayHarshil D Dhruv, Alison Roos, Patrick J Tomboc, et al.
Frontiers in Oncology|December 12, 2024
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1Zachary D Wallen, Mary K Nesline, Marni Tierno, et al.
Neuro-Oncology|June 14, 2018
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistanceDavid S Hersh, Bryan G Harder, Alison Roos, et al.
Molecular Cancer Research : MCR|January 15, 2016
SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to TemozolomideShannon P Fortin Ensign, Alison Roos, Ian T Mathews, et al.
Molecular Cancer Research : MCR|May 5, 2018
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and SurvivalAlison Roos, Harshil D Dhruv, Sen Peng, et al.
Pageof 2